Assessing Anti-SARS-CoV-2 Cellular Immunity in 571 Vaccines by Using an IFN-γ Release Assay

Overview

Journal Eur J Immunol

Specialty Allergy & Immunology

Date 2022 Oct 17

PMID 36250411

Authors

Masatoshi Wakui

Yoshifumi Uwamino

Yoko Yatabe

Terumichi Nakagawa

Akiko Sakai

Toshinobu Kurafuji

Ayako Shibata

Yukari Tomita

Masayo Noguchi

Akiko Tanabe

Tomoko Arai

Akemi Ohno

Hiromitsu Yokota

Shunsuke Uno

Wakako Yamasawa

Yasunori Sato

Mari Ikeda

Akihiko Yoshimura

Naoki Hasegawa

Hideyuki Saya

Mitsuru Murata

Affiliations

Soon will be listed here.

Abstract

Memory T cell responses have been analyzed only in small cohorts of COVID-19 vaccines. Herein, we aimed to assess anti-SARS-CoV-2 cellular immunity in a large cohort using QuantiFERON assays, which are IFN-γ release assays (IGRAs) based on short-term whole blood culture. The study included 571 individuals receiving the viral spike (S) protein-expressing BNT162b2 mRNA vaccine. QuantiFERON assays revealed antigen-specific IFN-γ production in most individuals 8 weeks after the second dose. Simultaneous flow cytometric assays to detect T cells expressing activation-induced markers (AIMs) performed for 28 randomly selected individuals provided data correlating with the QuantiFERON data. Simultaneous IFN-γ enzyme-linked immunospot and AIM assays for another subset of 31 individuals, based on short-term peripheral blood mononuclear cell culture, also indicated a correlation between IFN-γ production and AIM positivity. These observations indicated the acquisition of T cell memory responses and supported the usability of IGRAs to assess cellular immunity. The QuantiFERON results were weakly correlated with serum IgG titers against the receptor-binding domain of the S protein and were associated with pre-vaccination infection and adverse reactions after the second dose. The present study revealed cellular immunity after COVID-19 vaccination, providing insights into the effects and adverse reactions of vaccination.

Citing Articles

Natural and hybrid immunity after SARS-CoV-2 infection in children and adolescents.

Rothoeft T, Maier C, Talarico A, Hoffmann A, Schlegtendal A, Lange B Infection. 2024; 52(4):1449-1458.

PMID: 38499828 PMC: 11288991. DOI: 10.1007/s15010-024-02225-w.

Long-Term Immune Response Profiles to SARS-CoV-2 Vaccination and Infection in People with Multiple Sclerosis on Anti-CD20 Therapy.

Woopen C, Dunsche M, Al Rahbani G, Dillenseger A, Atta Y, Haase R Vaccines (Basel). 2023; 11(9).

PMID: 37766140 PMC: 10537223. DOI: 10.3390/vaccines11091464.

Waning cellular immune responses and predictive factors in maintaining cellular immunity against SARS-CoV-2 six months after BNT162b2 mRNA vaccination.

Ishii T, Hamada K, Jubishi D, Hashimoto H, Okamoto K, Hisasue N Sci Rep. 2023; 13(1):9607.

PMID: 37311763 PMC: 10263378. DOI: 10.1038/s41598-023-36397-6.

New Flow Cytometric Methods for Monitoring STAT5 Signaling Reveal Responses to SARS-CoV-2 Antigen-Specific Stimulation in FOXP3+ Regulatory T Cells also in Patients with Advanced Chronic Lymphocytic Leukemia.

Roskar Z, Dreisinger M, Tic P, Homsak E, Bevc S, Goropevsek A Biosensors (Basel). 2023; 13(5).

PMID: 37232900 PMC: 10216754. DOI: 10.3390/bios13050539.

Assessing SARS-CoV-2-specific T-cell reactivity in late convalescents and vaccinees: Comparison and combination of QuantiFERON and activation-induced marker assays, and relation with antibody status.

Gatti A, Zizzo G, De Paschale M, Tamburello A, Castelnovo L, Faggioli P PLoS One. 2023; 18(5):e0285728.

PMID: 37220145 PMC: 10204942. DOI: 10.1371/journal.pone.0285728.

References

Nadat F, Morbey J, Clark B, Welbury Smith M, Daga S, Ahmed A . Fresh versus frozen PMBC using the SARS CoV-2 T-SPOT.COVID test. Which works best?. J Immunol Methods. 2022; 506:113278. PMC: 9074295. DOI: 10.1016/j.jim.2022.113278. View

Gensous N, Charrier M, Duluc D, Contin-Bordes C, Truchetet M, Lazaro E . T Follicular Helper Cells in Autoimmune Disorders. Front Immunol. 2018; 9:1637. PMC: 6056609. DOI: 10.3389/fimmu.2018.01637. View

Crotty S . T follicular helper cell differentiation, function, and roles in disease. Immunity. 2014; 41(4):529-42. PMC: 4223692. DOI: 10.1016/j.immuni.2014.10.004. View

Sahin U, Muik A, Derhovanessian E, Vogler I, Kranz L, Vormehr M . COVID-19 vaccine BNT162b1 elicits human antibody and T1 T cell responses. Nature. 2020; 586(7830):594-599. DOI: 10.1038/s41586-020-2814-7. View

Grifoni A, Weiskopf D, Ramirez S, Mateus J, Dan J, Rydyznski Moderbacher C . Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals. Cell. 2020; 181(7):1489-1501.e15. PMC: 7237901. DOI: 10.1016/j.cell.2020.05.015. View

Tovey M, Lallemand C . Safety, Tolerability, and Immunogenicity of Interferons. Pharmaceuticals (Basel). 2016; 3(4):1162-1186. PMC: 4034027. DOI: 10.3390/ph3041162. View

Ma X, Nakayamada S . Multi-Source Pathways of T Follicular Helper Cell Differentiation. Front Immunol. 2021; 12:621105. PMC: 7947315. DOI: 10.3389/fimmu.2021.621105. View

Pedersen R, Tornby D, Bistrup C, Johansen I, Andersen T, Justesen U . Negative SARS-CoV-2 antibodies, T-cell response and virus neutralization following full vaccination in a renal transplant recipient: a call for vigilance. Clin Microbiol Infect. 2021; 27(9):1371-1373. PMC: 8180445. DOI: 10.1016/j.cmi.2021.05.042. View

Lange A, Borowik A, Bochenska J, Rossowska J, Jaskula E . Immune Response to COVID-19 mRNA Vaccine-A Pilot Study. Vaccines (Basel). 2021; 9(5). PMC: 8150284. DOI: 10.3390/vaccines9050488. View

10.

Crespo M, Barrilado-Jackson A, Padilla E, Eguia J, Echeverria-Esnal D, Cao H . Negative immune responses to two-dose mRNA COVID-19 vaccines in renal allograft recipients assessed with simple antibody and interferon gamma release assay cellular monitoring. Am J Transplant. 2021; 22(3):786-800. PMC: 8653097. DOI: 10.1111/ajt.16854. View

11.

Chen W, Yang F, Xu G, Ma J, Lin J . Follicular helper T cells and follicular regulatory T cells in the immunopathology of primary Sjögren's syndrome. J Leukoc Biol. 2020; 109(2):437-447. DOI: 10.1002/JLB.5MR1020-057RR. View

12.

Dagan N, Barda N, Kepten E, Miron O, Perchik S, Katz M . BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting. N Engl J Med. 2021; 384(15):1412-1423. PMC: 7944975. DOI: 10.1056/NEJMoa2101765. View

13.

Schwarz T, Tober-Lau P, Hillus D, Helbig E, Lippert L, Thibeault C . Delayed Antibody and T-Cell Response to BNT162b2 Vaccination in the Elderly, Germany. Emerg Infect Dis. 2021; 27(8):2174-2178. PMC: 8314803. DOI: 10.3201/eid2708.211145. View

14.

Diab R, Araghi F, Gheisari M, Kani Z, Moravvej H . Lichen planus and lichen planopilaris flare after COVID-19 vaccination. Dermatol Ther. 2021; 35(3):e15283. DOI: 10.1111/dth.15283. View

15.

Espi M, Charmetant X, Barba T, Koppe L, Pelletier C, Kalbacher E . The ROMANOV study found impaired humoral and cellular immune responses to SARS-CoV-2 mRNA vaccine in virus-unexposed patients receiving maintenance hemodialysis. Kidney Int. 2021; 100(4):928-936. PMC: 8286235. DOI: 10.1016/j.kint.2021.07.005. View

16.

Ebinger J, Fert-Bober J, Printsev I, Wu M, Sun N, Prostko J . Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2. Nat Med. 2021; 27(6):981-984. PMC: 8205849. DOI: 10.1038/s41591-021-01325-6. View

17.

Nakayamada S, Kanno Y, Takahashi H, Jankovic D, Lu K, Johnson T . Early Th1 cell differentiation is marked by a Tfh cell-like transition. Immunity. 2011; 35(6):919-31. PMC: 3244883. DOI: 10.1016/j.immuni.2011.11.012. View

18.

Papakyriakou A, Stratikos E . The Role of Conformational Dynamics in Antigen Trimming by Intracellular Aminopeptidases. Front Immunol. 2017; 8:946. PMC: 5545687. DOI: 10.3389/fimmu.2017.00946. View

19.

DellAringa M, Reinhardt R . Notch signaling represents an important checkpoint between follicular T-helper and canonical T-helper 2 cell fate. Mucosal Immunol. 2018; 11(4):1079-1091. PMC: 6030499. DOI: 10.1038/s41385-018-0012-9. View

20.

Tan S, Zhang J, Sun Y, Gistera A, Sheng Z, Malmstrom R . Platelets enhance CD4+ central memory T cell responses via platelet factor 4-dependent mitochondrial biogenesis and cell proliferation. Platelets. 2021; 33(3):360-370. DOI: 10.1080/09537104.2021.1936479. View